Gilead Sciences Inc
NASDAQ: GILD
$94.35
-$2.68 (-2.8%)
Closing Price on November 12, 2024
GILD Articles
24/7 Wall St. looks at some big analyst calls that we have seen so far on Friday, including Amazon, CME, Gilead Sciences and Twitter.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including Airbnb, Amazon, Fisker, Peloton, Uber and more.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including Booking, Expedia, FuelCell, Plug Power, Roku and more.
Published:
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
Published:
Tuesday's top analyst upgrades and downgrades included Airbnb, American Express, Arch Capital, Carlyle, Darden Restaurants, Facebook, Eli Lilly and Nio.
Published:
As earnings season begins, Lululemon Athletica and other companies are updating guidance for the quarter just ended and for the 2020 fiscal year.
Published:
Although the markets may be falling, 24/7 Wall St. is taking a look at some big analyst calls that we have seen so far on Monday.
Published:
Thursday's top analyst upgrades and downgrades included AT&T, Boeing, ConocoPhillips, Gilead Sciences, Illumina, Lam Research, Raytheon Technologies and Yum Brands.
Published:
Galapagos was crushed on Wednesday after the firm, in conjunction with Gilead, announced a new commercialization and development agreement for their Rheumatoid Arthritis (RA) treatment.
Published:
The November 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
The November 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Here is an update on the stocks of each major player in the COVID-19 arena, including brief trading histories and consensus price targets.
Published:
Thursday's top analyst upgrades and downgrades included Amgen, Boeing, eBay, Etsy, Fastly, Fiverr, Ford, General Electric, Gilead Sciences, Pinterest and Six Flags.
Published:
Amgen and Gilead released their most recent financial results after the closing bell on Wednesday.
Published:
The October 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published: